Grassley Seeks Meeting With Von Eschenbach To Assess Agency’s Drug Information Needs
This article was originally published in The Pink Sheet Daily
Executive Summary
Senator also asks Amgen CEO Sharer to brief his staff on EPO data allegedly withheld from the agency.